Why digital health investors are hopeful about 2025

The latest stories trending on MedCity News.

Editor's Pick

Top Story How Did Digital Health Investors View This Year's Funding Environment — and What Do They Predict for 2025? This year has seen a slight decline in digital health funding, but investors are still optimistic about the landscape. In 2024, investors poured millions into startups selling AI-powered healthcare tools, and this is likely to remain true for years to come. Sponsored Transforming Patient Care: The Role of AI-Powered Assistants Presented by IT Medical The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes. Learn More Discover a Healthier Future with Green Chef! Fuel Your Health with Green Chef: 50% Off + Free Salads for the first 2 Months! Why Join? 🌱 No GMO's, pesticides or antibiotics 🍴 Ingredients come pre-measured and prepped ⏱️ Recipes are ready in 30 minutes Join Today

Featured News

MedCity Pivot Podcast: Putting a Human Touch on Healthcare Navigation and Coordination Heather Cox, President of Insights & Empowerment at Zelis, talked about the company's care coordination tools with MedCity News Reporter Katie Adams. Culina Health Snags $7.9M to Expand Access to Nutrition Care Culina Health's Series A round was led by Healthworx, the investment arm of insurer CareFirst. It also included participation from Rethink Impact, Collab Capital, Collide Capital, Vamos Ventures, Tensility Venture Partners, Cake Ventures and GW Ventures. How Can Self-Insured Employers Identify Ways to Rein in Healthcare Costs? In a webinar sponsored by Personify Health, executives from international chemical company Dow and the National Alliance of Healthcare Purchaser Coalitions discussed some of the tough choices companies are making. AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More Applications of SandboxAQ's large quantitative models (LQMs) technology include running simulations that identify new biomarkers and optimize clinical development of drug candidates. The company spun out of Alphabet in 2022. Less Is More: The Power of Consolidation & Shared Governance in Health Tech Optimization To avoid adding to the patchwork of disparate systems, healthcare leaders must balance their workforce's eagerness to adopt new technologies with a focus on the consolidation of the right solutions. Here's where to begin.  Unlocking AI Explainability for Trustworthy Healthcare AI should augment, not replace, human provider expertise. Explainability empowers healthcare professionals to work in tandem with AI, ensuring that patients receive the most accurate and informed care.

Resources

SPONSORED MedCity Pivot Podcast: Self-insured Employers Weigh Benefits of GLP-1 Drugs In a conversation with MedCity News Editor-in-Chief Arundhati Parmar, Personify Health Chief Medical Officer Jeff Jacques talks about the different types of GLP-1 drugs, what portion of employers currently offer the medications, and how many employers are considering making them part of their health benefit offering in the future. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe